These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 37112619)

  • 1. The Skin Sensitisation of Cosmetic Ingredients: Review of Actual Regulatory Status.
    Bialas I; Zelent-Kraciuk S; Jurowski K
    Toxics; 2023 Apr; 11(4):. PubMed ID: 37112619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a next generation risk assessment framework for the evaluation of skin sensitisation of cosmetic ingredients.
    Gilmour N; Kern PS; Alépée N; Boislève F; Bury D; Clouet E; Hirota M; Hoffmann S; Kühnl J; Lalko JF; Mewes K; Miyazawa M; Nishida H; Osmani A; Petersohn D; Sekine S; van Vliet E; Klaric M
    Regul Toxicol Pharmacol; 2020 Oct; 116():104721. PubMed ID: 32645429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COSMOS next generation - A public knowledge base leveraging chemical and biological data to support the regulatory assessment of chemicals.
    Yang C; Cronin MTD; Arvidson KB; Bienfait B; Enoch SJ; Heldreth B; Hobocienski B; Muldoon-Jacobs K; Lan Y; Madden JC; Magdziarz T; Marusczyk J; Mostrag A; Nelms M; Neagu D; Przybylak K; Rathman JF; Park J; Richarz AN; Richard AM; Ribeiro JV; Sacher O; Schwab C; Vitcheva V; Volarath P; Worth AP
    Comput Toxicol; 2021 Aug; 19():100175. PubMed ID: 34405124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010.
    Adler S; Basketter D; Creton S; Pelkonen O; van Benthem J; Zuang V; Andersen KE; Angers-Loustau A; Aptula A; Bal-Price A; Benfenati E; Bernauer U; Bessems J; Bois FY; Boobis A; Brandon E; Bremer S; Broschard T; Casati S; Coecke S; Corvi R; Cronin M; Daston G; Dekant W; Felter S; Grignard E; Gundert-Remy U; Heinonen T; Kimber I; Kleinjans J; Komulainen H; Kreiling R; Kreysa J; Leite SB; Loizou G; Maxwell G; Mazzatorta P; Munn S; Pfuhler S; Phrakonkham P; Piersma A; Poth A; Prieto P; Repetto G; Rogiers V; Schoeters G; Schwarz M; Serafimova R; Tähti H; Testai E; van Delft J; van Loveren H; Vinken M; Worth A; Zaldivar JM
    Arch Toxicol; 2011 May; 85(5):367-485. PubMed ID: 21533817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuing animal tests on cosmetic ingredients for REACH in the EU.
    Knight J; Rovida C; Kreiling R; Zhu C; Knudsen M; Hartung T
    ALTEX; 2021; 38(4):653-668. PubMed ID: 34402521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current EU regulatory requirements for the assessment of chemicals and cosmetic products: challenges and opportunities for introducing new approach methodologies.
    Pistollato F; Madia F; Corvi R; Munn S; Grignard E; Paini A; Worth A; Bal-Price A; Prieto P; Casati S; Berggren E; Bopp SK; Zuang V
    Arch Toxicol; 2021 Jun; 95(6):1867-1897. PubMed ID: 33851225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro testing strategy for assessing the skin sensitizing potential of "difficult to test" cosmetic ingredients.
    Bergal M; Puginier M; Gerbeix C; Groux H; Roso A; Cottrez F; Milius A
    Toxicol In Vitro; 2020 Jun; 65():104781. PubMed ID: 32001296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk assessment of nanomaterials in cosmetics: a European union perspective.
    Henkler F; Tralau T; Tentschert J; Kneuer C; Haase A; Platzek T; Luch A; Götz ME
    Arch Toxicol; 2012 Nov; 86(11):1641-6. PubMed ID: 23052193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of an integrated project (Sens-it-iv) to develop in vitro tests to assess sensitisation.
    Rovida C; Basketter D; Casati S; de Silva O; Hermans H; Kimber I; Manou I; Weltzien HU; Roggen E
    Altern Lab Anim; 2007 Jun; 35(3):317-22. PubMed ID: 17650950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of non-animal alternatives in the safety evaluations of cosmetics ingredients by the Scientific Committee on Consumer Safety (SCCS).
    Vinardell MP
    Regul Toxicol Pharmacol; 2015 Mar; 71(2):198-204. PubMed ID: 25555996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SCCS Notes of Guidance for the testing of cosmetic ingredients and their safety evaluation, 11th revision, 30-31 March 2021, SCCS/1628/21.
    ;
    Regul Toxicol Pharmacol; 2021 Dec; 127():105052. PubMed ID: 34653552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assuring consumer safety without animal testing: a feasibility case study for skin sensitisation.
    Maxwell G; Aleksic M; Aptula A; Carmichael P; Fentem J; Gilmour N; Mackay C; Pease C; Pendlington R; Reynolds F; Scott D; Warner G; Westmoreland C
    Altern Lab Anim; 2008 Nov; 36(5):557-68. PubMed ID: 19025323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety assessment of a novel active ingredient, acetyl aspartic acid, according to the EU Cosmetics Regulation and the Scientific Committee on Consumer Safety guidelines.
    Daly P; Moran G
    Int J Cosmet Sci; 2015 Oct; 37 Suppl 1():21-7. PubMed ID: 26114401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety assessment of personal care products/cosmetics and their ingredients.
    Nohynek GJ; Antignac E; Re T; Toutain H
    Toxicol Appl Pharmacol; 2010 Mar; 243(2):239-59. PubMed ID: 20005888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Final report of the safety assessment of niacinamide and niacin.
    Cosmetic Ingredient Review Expert Panel
    Int J Toxicol; 2005; 24 Suppl 5():1-31. PubMed ID: 16596767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
    Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
    Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human health safety evaluation of cosmetics in the EU: a legally imposed challenge to science.
    Pauwels M; Rogiers V
    Toxicol Appl Pharmacol; 2010 Mar; 243(2):260-74. PubMed ID: 20006634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview of current practices for regulatory risk assessment with lessons learnt from cosmetics in the European Union.
    Arnesdotter E; Rogiers V; Vanhaecke T; Vinken M
    Crit Rev Toxicol; 2021 May; 51(5):395-417. PubMed ID: 34352182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Final amended report on the safety assessment of Methylparaben, Ethylparaben, Propylparaben, Isopropylparaben, Butylparaben, Isobutylparaben, and Benzylparaben as used in cosmetic products.
    Int J Toxicol; 2008; 27 Suppl 4():1-82. PubMed ID: 19101832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative in vitro models used in the main safety tests of cosmetic products and new challenges.
    Filaire E; Nachat-Kappes R; Laporte C; Harmand MF; Simon M; Poinsot C
    Int J Cosmet Sci; 2022 Dec; 44(6):604-613. PubMed ID: 35842748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.